Findings
========

Both low high-density lipoprotein cholesterol (HDL), and impaired cognitive function are prevalent concomitants of aging in industrialized nations \[[@B1],[@B2]\]. Studies of HDL and cognitive function and Alzheimer\'s disease suggest a possible negative association \[[@B3]\]. Recently HDL has been found to play important roles in brain pathophysiology \[[@B4]-[@B6]\]. Cognitive function has been found to predict subsequent mortality in elderly adults in a number of previous studies \[[@B7]\]. Mechanisms remain obscure. High HDL has been found to be negatively related to increased mortality from cardiovascular disease \[[@B8],[@B9]\]. Mechanisms may include tissue cholesterol removal, fibrinolytic activity, hemostatic function, inflammation and oxidative stress leading to less atherosclerosis. However, information regarding interactions of cognitive function and HDL cholesterol are lacking in studies of mortality.

We test the hypothesis that the effect of HDL on mortality is modified by cognitive function score, the effect being less among those with high compared to those with low scores. We analyzed available data from a national health examination survey linked-mortality file conducted with scientific sampling and state-of-the-art interviewing, examination and laboratory methods.

The Third National Health and Nutrition Examination Survey (NHANES III) was conducted in 1988-1994 on a nationwide multi-stage probability sample of 39,695 persons from the civilian, non-institutionalized population aged 2 months and over of the United States. Persons aged 60 and over, African Americans, and Mexican Americans were oversampled. Details of the plan, sampling, operation, response and institutional review board approval have been published as have procedures used to obtain informed consent and to maintain confidentiality of information obtained \[[@B10]\]. The personal interviews and physical and laboratory examinations of NHANES III subjects provided the baseline data for the study. This analysis was based on the public-use version of the NHANES III linked-mortality file with mortality data through 2000. Of 33,994 persons with baseline interview data, 13,944 were under age 17 and 26 lacked data for matching leaving 20,024 eligible for mortality follow-up. The NHANES III linked mortality file contains information based upon the results from a probabilistic match between NHANES III and the NCHS National Death Index records. The NHANES III linked mortality file provides mortality follow-up data from the date of NHANES III survey participation (1988-1994) through December 31, 2000.

Of the 20,022 interviewed persons with mortality follow-up, 6588 were aged 60 years and over and eligible to have cognitive function testing performed, 6339 of whom had valid cognitive function data. After excluding persons with missing data for any of the variables shown in the tables, 4,911 persons aged 60 and over with complete data remained for mortality analyses. The length of follow-up of survivors ranged from 75 to 146 months, mean 108 months, median 107 months.

HDL. Serum lipids were measured at the Centers for Disease Control and Prevention in Atlanta, Georgia. HDL was measured in serum following the precipitation of other lipoproteins with a polyanion/divalent cation mixture. For descriptive analysis, quartiles of HDL concentration were formed. For regression analysis, persons with concentrations below 40 mg/dL were compared to those with 40 mg/dL and greater.

Cognitive Function. Questions assessing mental cognition were asked only of respondents aged 60 or older and not to proxy respondents. These questionnaires were designed for administration in a bilingual (English/Spanish) format so that respondents could be interviewed in their preferred language. The neuropsychological measures used in the NHANES III study, were selected to assess dimensions of cognitive function typically affected in dementia. A short cognitive function index (SICF) was constructed for this analysis from these items administered at home interview and/or at a Mobile Examination Center to assess orientation, recall and attention \[[@B11],[@B12]\]. A higher score indicates a higher level of cognitive function compared to a lower score. Approximate quartiles were formed. For regression analysis, persons with scores below the median were compared to those with scores above the median.

Estimates of the risk of death derive from Cox proportional hazards regression models with time to event as the time scale computed using the SURVIVAL procedure in SUDAAN. Survivors were censored at the date of the end of mortality follow-up. Logistic regression models were also done to confirm key findings.

Table [1](#T1){ref-type="table"} shows characteristics of persons aged 60+ by HDL level. In multivariate linear regression analyses, HDL was not independently associated with SICF (not shown). In proportional hazards regression models, persons with a lower compared to a higher SICF score had increased adjusted hazard of mortality (Table [2](#T2){ref-type="table"}). Compared to those with HDL \>40 mg/dL those with HDL of \< = 40 mg/dL had increased adjusted hazard of mortality (Table [2](#T2){ref-type="table"}). No significant interaction of SICF score and HDL was detected (p = 0.08). However, a significant interaction of age was seen with both SICF and HDL, the adjusted effect of both on mortality increasing with advancing age (Table [2](#T2){ref-type="table"}). Table [2](#T2){ref-type="table"} shows fully adjusted hazards ratios, indicating independent associations of HDL and SICF score with survival, with strongest, significant associations among the oldest persons. Much of the association of HDL could be explained statistically by controlling for physical activity level confirming its likely causal association with both HDL level and mortality.

###### 

Prevalence (%) of selected characteristics by quartile of high density lipoprotein cholesterol (HDL-C) concentration in persons aged 60y and over (N = 4911).

                             HDL-C quartile                  
  -------------------------- ---------------- ---- ---- ---- ----
  Dead                       32               36   31   28   31
  Cognitive function index                                   
   \<12                      20               17   22   18   21
   12-13                     37               25   36   37   38
   14-16                     19               22   19   19   17
   17                        25               25   24   25   24
  Female                     57               34   53   64   79
  Age 70+                    49               46   50   50   51
  Mexican American           2                2    3    2    2
  African American           8                5    7    8    11
  South region               31               31   33   32   26
  Metropolitan residence     44               41   46   39   48
  Unmarried                  40               30   36   43   50
  Education \< 12 y          41               46   41   40   36
  Fair-poor health           28               34   31   22   25
  ≥1 chronic illness         56               62   57   54   51
  Mobility limitation        33               33   35   31   33
  Current smoking            15               16   14   15   14
  Alcohol in past month      35               29   31   37   43
  No regular physician       15               15   14   14   16
  No religious attendance    12               10   12   14   12
  Systolic BP ≥140 mmHg      51               50   51   54   47
  BMI ≥30 kg/m2              23               29   27   22   15
  No physical activity       79               79   78   81   77

###### 

Adjusted hazards ratios\* of high density lipoprotein cholesterol, short index of cognitive function (SICF) for survival in persons aged 60 years and over.

              All                Age 60-69         Age 70-79         Age 80+
  ----------- ------------------ ----------------- ----------------- ---------------------
              **HR (95% CL)**                                        
                                                                     
  HDL                                                                
                                                                     
  \< = 40     1.20 (0.99-1.46)   0.92(0.67-1.27)   1.19(0.87-1.64)   1.33(1.12-1.58)\*\*
                                                                     
  \>40        1.00               1.00              1.00              1.00
                                                                     
  SICF                                                               
                                                                     
  \<13.6      1.09(0.93-1.29)    1.11(081-1.53)    1.10(0.85-1.42)   1.32(1.11-1.57)\*\*
                                                                     
  \> = 13.6   1.00               1.00              1.00              1.00
                                                                     
  N                              1947              1442              915

\*adjusted for age, gender, ethnicity, education, comorbidity, region, urbanization, health status, mobility, blood pressure, smoking, alcohol, physical activity

\*\*P \< 0.01; +P \< 0.05

This analysis of data from the NHANES III linked-mortality file, a nation-wide representative sample, tested for interaction of cognitive function and HDL as predictors of survival in older Americans. Both low HDL and poor cognitive function were found to independently predict poor survival chances over follow-up. However, no interaction of the two was detected. Effects increased with age. However, a previously reported association between HDL and cognitive function could not be replicated. The NHANES III provides population-based data on the association of HDL, cognitive function, and survival in a nation-wide representative sample of Americans. Oversampling of persons aged 60 and over permitted reliable estimates for this group. However, several unavoidable limitations of the present study include possible bias arising from survey non-response and missing values for some variables and from possible changes in HDL and cognitive function and/or other variables over the follow-up period. Adjusting for age, HDL and SICF were also independently associated with death in logistic regression models (p \< 0.01) with no significant interaction between them (p = 0.48). Further longitudinal studies with measures of HDL subtypes, apolipoprotein A-1, apoE, and multiple dimensions of cognition and Alzheimer\'s disease biomarkers would be helpful.
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